Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19

Coronavirus disease 2019 (COVID-19) caused by the previously unknown pathogen, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is now a global pandemic. There are no vaccines or specific treatments against this new virus; therefore, there is an urgent need to advance novel thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Pan, Liu, Dong, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180159/
https://www.ncbi.nlm.nih.gov/pubmed/32335281
http://dx.doi.org/10.1016/j.ijantimicag.2020.105995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180159/
https://www.ncbi.nlm.nih.gov/pubmed/32335281
http://dx.doi.org/10.1016/j.ijantimicag.2020.105995

Ejemplares similares